Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2026-02-25 @ 2:35 AM
Study NCT ID:
NCT02324595
Status:
COMPLETED
Last Update Posted:
2016-04-13
First Post:
2014-06-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study
Sponsor:
Catholic University of the Sacred Heart
Organization:
Study Overview
Official Title:
Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MISSION
Brief Summary:
Phase II multicentric study
Detailed Description:
The aim of this prospective Phase II multicentric study is to assess feasibility and early complications rate of "total laparoscopic/robotic" interval debulking surgery in patients with a clinical complete/partial response to neoadjuvant chemotherapy for advanced ovarian cancer.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: